We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.6B
AUM Growth
+$404M
Cap. Flow
-$918M
Cap. Flow %
-4.46%
Top 10 Hldgs %
45.88%
Holding
486
New
43
Increased
157
Reduced
204
Closed
61

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$271M
2
CEG icon
Constellation Energy
CEG
+$108M
3
HUBS icon
HubSpot
HUBS
+$83.9M
4
AAPL icon
Apple
AAPL
+$83.5M
5
EQIX icon
Equinix
EQIX
+$56.3M

Sector Composition

Rank Sector Weight
1 Technology 41.24%
2 Healthcare 15.44%
3 Communication Services 13.11%
4 Consumer Discretionary 10.67%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CG icon
326
Carlyle Group
CG
$16.7B
$1.79M 0.01%
44,603
+3,059
+7% +$132K
MLAB icon
327
Mesa Laboratories
MLAB
$559M
$1.78M 0.01%
20,570
-172
-0.8% -$18K
BMY icon
328
Bristol-Myers Squibb
BMY
$130B
$1.72M 0.01%
41,496
+3,726
+10% +$167K
FLNC icon
329
Fluence Energy
FLNC
$1.68B
$1.71M 0.01%
98,733
+70,354
+248% +$1.35M
MEDP icon
330
Medpace
MEDP
$15.9B
$1.69M 0.01%
+4,103
New +$1.62M
THC icon
331
Tenet Healthcare
THC
$22.6B
$1.69M 0.01%
12,690
-11,156
-47% -$1.34M
WAY
332
Waystar Holding Corp
WAY
$4.54B
$1.67M 0.01%
+77,787
New +$1.69M
ACHC icon
333
Acadia Healthcare
ACHC
$3.01B
$1.63M 0.01%
24,116
-1,148,363
-98% -$80.2M
BILL icon
334
BILL Holdings
BILL
$4.62B
$1.59M 0.01%
30,158
-943
-3% -$53.4K
GSK icon
335
GSK
GSK
$108B
$1.58M 0.01%
41,068
XPO icon
336
XPO
XPO
$24B
$1.56M 0.01%
14,721
-532
-3% -$59.6K
BOOT icon
337
Boot Barn
BOOT
$4.81B
$1.55M 0.01%
+12,029
New +$1.35M
UHS icon
338
Universal Health Services
UHS
$10.1B
$1.55M 0.01%
+8,383
New +$1.48M
MXCT icon
339
MaxCyte
MXCT
$112M
$1.54M 0.01%
393,772
-5,390
-1% -$23.2K
NKE icon
340
Nike
NKE
$63.9B
$1.48M 0.01%
19,701
-17,798
-47% -$1.65M
CAKE icon
341
Cheesecake Factory
CAKE
$4.42B
$1.48M 0.01%
+37,665
New +$1.4M
CRM icon
342
Salesforce
CRM
$149B
$1.45M 0.01%
5,653
-25,224
-82% -$6.75M
BCPC
343
Balchem Corp
BCPC
$5.33B
$1.43M 0.01%
9,306
-7,865
-46% -$1.18M
BHVN icon
344
Biohaven
BHVN
$2.07B
$1.4M 0.01%
40,294
-10,810
-21% -$427K
DOW icon
345
Dow Inc
DOW
$20.8B
$1.35M 0.01%
25,426
SNPS icon
346
Synopsys
SNPS
$73.5B
$1.34M 0.01%
2,246
-9,923
-82% -$5.61M
OKLO
347
Oklo
OKLO
$6.89B
$1.29M 0.01%
+152,591
New +$1.72M
TXG icon
348
10x Genomics
TXG
$5.97B
$1.28M 0.01%
65,973
-379,594
-85% -$9.94M
RDDT icon
349
Reddit
RDDT
$34.4B
$1.26M 0.01%
19,756
-199
-1% -$10.5K
MBLY icon
350
Mobileye
MBLY
$2.13B
$1.26M 0.01%
44,920
-2,793,160
-98% -$80.9M

Similar funds

Fred Alger Management's Q2 2024 Portfolio in Review

As of Q2 2024, Fred Alger Management held 486 positions worth $20.6B, up 2% from $20.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fred Alger Management withdrew a net $918M in Q2 2024, closing 61 positions and reducing 204 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $67.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Fred Alger Management opened a new position in Applovin worth $291M.

  • Fred Alger Management's largest Q2 2024 buy was Applovin: 3,492,613 shares worth $291M.
  • Fred Alger Management added most to Constellation Energy in Q2 2024, an estimated $108M increase.
  • Fred Alger Management's biggest Q2 2024 reduction was Natera, cutting an estimated $130M.
  • Fred Alger Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $67.4M.
  • Fred Alger Management's ten largest holdings make up 46% of its $20.6B portfolio in Q2 2024.
  • Fred Alger Management opened 43 new positions and closed 61 in Q2 2024.
  • Fred Alger Management's portfolio value rose 2% quarter-over-quarter to $20.6B.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.